Technology | Telecardiology | July 19, 2016

Dictum Health Initiates Telehealth Study for Neonate Cardiology

Study will assess impact of Virtual Examination Room on outcomes, readmission rates for post-surgical neonate patients

Dictum Health, telehealth study, IDM100 tablet, neonate cardiology, in-home monitoring

July 19, 2016 — Dictum Health Inc. announced the launch of a post-U.S. Food and Drug Administration (FDA)-approval study of its end-to-end telehealth care-delivery system with University of California Davis Medical Center in Sacramento.

The study will demonstrate the effectiveness of Dictum Health’s end-to-end telehealth system, built upon its FDA-cleared, cyber-secure IDM100 integrated medical tablet. The tablet uses a HIPAA-compliant cloud and Care Central portal that enables a completely private Virtual Exam Room (VER) for in-home monitoring of high-risk infants. The neonatal cardiac care team will monitor the patients remotely and conduct examinations using VER. The goal is to improve clinical outcomes of children who have undergone surgery for single-ventricle hypoplastic left heart syndrome and are receiving post-surgical care at home.

Patients will use the VER to see a physician while simultaneously streaming real-time vital signs, cardiopulmonary data, medical images, analytics and trending information. Each of the 25 patients selected each year for the study will be assigned an IDM100 tablet upon hospital discharge for regular monitoring at home using live video and vital-signs management functions.

The study will evaluate how the VER’s live video streaming, vital-signs management and simultaneous real-time biometric data streaming through a secure, Web-enabled portal enhances home monitoring of at-risk infants. The study will also measure hospital readmission rates for these post-surgical patients and assess levels of acceptance of this technology by both providers and family caregivers.

For more information: www.dictumhealth.com

Related Content

The Smidt Heart Institute at Cedars-Sinai is working with the Keck Medicine of USC heart surgery team to expand care for children and adults with congenital heart disease. An echocardiographer helps with cardiac ultrasound imaging in a hybrid OR during a congenital case using a Siemens SC2000 imaging system. Photo by Cedars-Sinai.

The Smidt Heart Institute at Cedars-Sinai is working with the Keck Medicine of USC heart surgery team to expand care for children and adults with congenital heart disease. An echocardiographer helps with cardiac ultrasound imaging in a hybrid OR during a congenital case using a Siemens SC2000 imaging system. Photo by Cedars-Sinai.

News | Congenital Heart | August 10, 2020
August 10, 2020 - The...
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020

Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects.

News | Congenital Heart | May 21, 2020
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were pres
SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations. A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.

A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.

News | Congenital Heart | May 04, 2020
University of Arizona Leads Statewide Study of Congenital Heart Defects
News | Congenital Heart | October 24, 2019
Investigators at the University of Arizona Steele Children's Research Center are leading a statewide study as part of a...
Abbott Receives European CE Mark for Two Pediatric Heart Devices
News | Congenital Heart | September 20, 2019
Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm rotatable mechanical heart...
High Blood Pressure, Cholesterol in Young Adults Associated With Later Heart Disease
News | Congenital Heart | July 16, 2019
Elevated blood pressure and cholesterol levels in young adulthood may lead to an increased risk of heart disease later...
Hypertension Found in Children Exposed to Flower Pesticides
News | Congenital Heart | June 03, 2019
Researchers at University of California San Diego School of Medicine found higher blood pressure and pesticide...
Edwards Recalls Miller and Fogarty Balloon Dilation Atrioseptostomy Catheters
News | Congenital Heart | April 29, 2019
Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation Atrioseptostomy...
New Pediatric Blood Pressure Guidelines Improve Premature Heart Disease Identification
News | Congenital Heart | April 22, 2019
New guidelines that classified more children as having elevated blood pressure  are better at predicting which kids are...
Better Options Needed for Children at Higher Risk of Premature Heart Disease
News | Congenital Heart | February 28, 2019
Obesity and severe obesity in childhood and adolescence have been added to the list of conditions that put children and...